ロード中...
TGF-β causes Docetaxel resistance in Prostate Cancer via the induction of Bcl-2 by acetylated KLF5 and Protein Stabilization
Prostate cancer is the second leading cause of cancer-related death in the United States. As a first line treatment for hormone-refractory prostate cancer, docetaxel (DTX) treatment leads to suboptimal effect since almost all patients eventually develop DTX resistance. In this study, we investigated...
保存先:
| 出版年: | Theranostics |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Ivyspring International Publisher
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7359077/ https://ncbi.nlm.nih.gov/pubmed/32685011 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/thno.44567 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|